Rigetti Computing Inc (RGTI.NASDAQ) AI OPINIONS & ADVISOR ANALYSIS
Read the selected AI Advisor’s complete report, scenarios and forecast. Select Consensus for its investment thesis and a preview of advisor weights. Eligible access unlocks all 14 advisor reports and comparisons.
Updated on 20 September 2026Deep analysis 20 September 2026
Russlan Ramdowar
Opus 5Universal Investor AI
The Polymath FrameworkModel rating
Partial Sell
5-Year Return Est.
-21.5%
RGTI.NASDAQ does not currently pay dividends
Historical prices and published forecast
- Observed price
- Published advisor forecast
Quarterly Events ForecastPrice targets, total returns and complete scenario reasoning
Forecast prices in USD. Returns are cumulative from the forecast anchor. Swipe horizontally to read every column.
| Quarter | Forecast | Total return | Scenario |
|---|---|---|---|
| $14.50 | -8.0% | Year-end fidelity checkpoint approaches with slippage base rate unfavourable, while the 10Y near 5.0% and another possible Fed hike compress long-duration speculative multiples. Tax-loss selling in de-rated momentum names adds pressure. | |
| $15.95 | +1.2% | Q4 print recognizes the $8.4M C-DAC order, producing the largest quarterly revenue in company history and a headline beat. First Commerce milestone tranche of $43.9M provides visible validation, lifting the option premium temporarily. | |
| $14.04 | -10.9% | Post-catalyst air pocket as Q1 revenue reverts to single-digit millions and burn steps up toward $32M quarterly. Investors re-focus on the gap between research revenue and a multi-billion market capitalization. | |
| $13.19 | -16.3% | Rate regime remains restrictive with inflation sticky above target; capital rotates to cash-generative AI infrastructure. Rigetti's 1,000-qubit timeline is restated with softer language, trimming the catalyst calendar investors were paying for. | |
| $14.38 | -8.8% | Next-generation chiplet system announcement with improved median fidelity revives the thematic bid. Second Commerce tranche disbursement confirms political alignment intact, and year-end quantum conference cycle draws speculative flow back. | |
| $12.94 | -17.9% | Fresh at-the-market issuance to extend runway toward the advantage horizon dilutes per-share option value. Peer capital raises by Quantinuum and PsiQuantum erode Rigetti's scarcity premium as the listed superconducting pure-play. | |
| $13.59 | -13.8% | Easing policy expectations as inflation normalizes lower the discount rate applied to zero-cash-flow duration assets. Modest sovereign procurement orders from allied national labs provide incremental revenue visibility. | |
| $12.64 | -19.8% | Error-correction overhead reality check: 108-to-336 qubit scaling reveals integration complexity familiar from the Lyra delay history. Revenue growth remains lumpy and gross margin stays negative on hardware mix. | |
| $13.65 | -13.4% | Competitive milestone news across the sector lifts all quantum names as institutional allocators establish thematic positions. Rigetti's final Commerce tranche completion signals programme delivery, supporting a relief rally into year-end. | |
| $12.42 | -21.2% | The three-year advantage promise made in 2026 comes due and is not met, puncturing the schedule investors anchored on. Cash falls below $350M, raising the visibility of future dilution. | |
| $11.80 | -25.1% | Consolidation chatter across superconducting players pressures independents. Without an acquisition bid, Rigetti trades on burn arithmetic rather than narrative, with revenue still well short of covering quarterly R&D. | |
| $12.51 | -20.6% | Hybrid quantum-classical deployments with HPE and supercomputing centres generate repeat system orders, lifting annual revenue toward the thirty-million range. Incremental commercial proof supports a partial re-rating. | |
| $13.01 | -17.5% | Stabilizing rate environment and improved fidelity disclosures restore modest confidence. Year-end roadmap update frames a credible path to logical qubits, though timelines again extend beyond prior guidance. | |
| $11.97 | -24.1% | Renewed equity issuance funds the next fabrication expansion, adding shares against unchanged commercial traction. Federal appropriations uncertainty for follow-on quantum programmes weighs on the policy-support component of the valuation. | |
| $12.33 | -21.8% | Sector-wide progress on logical qubit demonstrations lifts sentiment. Rigetti participates but underperforms better-capitalized rivals, with the market increasingly discriminating between funded scale and funded survival. | |
| $11.59 | -26.5% | Revenue growth decelerates as national-lab procurement budgets normalize after the initial testbed buildout wave. Operating losses persist near $130M annually, keeping the cash-consumption clock visible to investors. | |
| $12.40 | -21.3% | Strategic partnership or consortium speculation returns as consolidation across the modality accelerates. Thematic year-end flow into quantum names lifts the stock despite unchanged underlying unit economics. | |
| $11.78 | -25.3% | Reality reasserts: five years after the CHIPS award, revenue remains under $100M against cumulative losses exceeding a billion. The option premium compresses toward a narrower, more defensible range. | |
| $12.01 | -23.8% | Stabilization near cash-plus-option value as the shareholder base rotates from momentum traders to longer-horizon thematic allocators. Volatility moderates while fundamental catalysts remain multi-year in nature. | |
| $12.37 | -21.5% | Incremental fidelity and qubit-count milestones deliver modest appreciation. The equity trades as a funded long-duration research option, repriced lower than 2026 but with a defended floor from remaining liquidity. |
1. Investment Thesis — Base Case
The central tension is that Rigetti has become impossible to kill and difficult to justify. A $541M debt-free balance sheet and a $100M milestone-gated federal award remove the financing-distress scenario that once defined the bear case [1][7]. But they do nothing for the revenue line, which remains research-budget money at roughly $13M TTM against a $5.25B market cap. Over five years I expect real technical progress, late relative to stated dates, modest revenue growth into the low tens of millions, continued dilution, and a valuation that grinds toward a lower but still option-rich multiple. The base case is negative total return with violent interim swings, not a collapse.
- Net cash near $1.60 per share means roughly 90% of the $15.76 close is milestone option value.
- Base case compresses that option premium toward $8-11 per share by 2031.
- At $13M TTM revenue, even 10x 2031 sales of $80M implies well under current cap.
2. Scenarios & Signals
2.1. Bull Case
Everything hinges on one verified number arriving on time. If 99.5% fidelity lands by end-2026 and the 1,000-qubit path stays credible, sovereign and national-lab procurement converts from pilots to multi-system orders, revenue steps toward $50-80M by 2029, and the federal stake attracts allied-government replication. That reflexive loop, credibility funding orders funding credibility, would restore a scarcity premium just as peers struggle with monolithic yields. The investment implication is asymmetric upside from a floor the cash pile defends.
2.2. Bear Case
The killer combination is a missed fidelity target inside a hostile discount-rate regime. Should 99.5% slip into 2027 while the Fed holds near 4% and thematic flow rotates to profitable AI infrastructure, the 300x sales multiple has no defence and retail turnover of roughly 5% daily accelerates the unwind [20]. Falling price forces larger ATM issuance per dollar raised, diluting the very option investors own. The result is slow erosion toward cash-plus-modest-option value, not a bankruptcy.
2.3. Behavioral Alpha Signals
Sentiment, repricing cycle, crowd narrative, catalyst, and macro alignment.Expected Volatility Regime
Greed and Fear Index
Cycle Position
The thesis is unwinding and reflexive decline is underway.
What does Media Tell? (Crowd Consensus)
The crowd treats Rigetti as the listed call option on American quantum supremacy, now with a federal co-signature. Nine buys, zero sells, and a $28.81 average target anchor on catalysts rather than cash flow [15]. Consensus assumes the CHIPS award validates the technology and that $541M cash guarantees survival to advantage. The anchoring bias is milestone dates treated as delivery dates.
What Crowds Get Wrong? (Alpha/Value Gap)
The crowd overestimates these shares, though less egregiously than in 2025. The blind spot is arithmetic: $1.60 per share of net cash against a $15.76 close means roughly 90% of the price discounts scientific outcomes management dates three years away [1][16]. Meanwhile GAAP earnings are warrant remeasurement noise, positive $33.1M in Q1 2026 and negative $52.6M in Q2, which masks the only honest scoreboard, a steady $28M quarterly burn [3][6]. Overpriced, but with a genuine cash floor beneath it.
When will Value Gap Repricing Happen? (Repricing Catalyst)
The December 2026 fidelity checkpoint is the trigger. Either 99.5% median two-qubit fidelity lands on schedule or the slippage base rate reasserts [14][17]. The first observable sign is the tone of the Q4 print alongside C-DAC revenue recognition; a target restated as "early 2027" begins the de-rating.
How is Asset Influenced by Macro Regime?
The macro wind is squarely in its face. A 3.75%-4.00% funds rate, a 10Y near 5.0% and a median dot implying another hike punish zero-cash-flow, ultra-long-duration equities through the discount rate. Rigetti has no revenue channel to offset it; only thematic flow sustains the multiple, and that flow is liquidity-dependent, not fundamentally anchored.
3. Positive & Negative Factors, Risks & Opportunities
3.1. Base-Case Forces
Near-certain positive forces
Top Drivers / Tailwinds
Structural or operating forces that support this advisor thesis. These forces are treated as part of the base case (more than 60% probability of occurrence).
Scroll to view all columns
| Driver / Tailwind | Category | Est. stock-price impact | Est. earnings impact | Why it matters |
|---|---|---|---|---|
| Washington BUYS A SEAT Funds THE LAB | Political And Geopolitical | +30% | +45% | The September 8, 2026 Commerce agreement grants Rigetti $100M in CHIPS R&D money in milestone tranches of $43.9M, $29.9M and $26.2M against a 7,739,938-share issuance at $12.92 [7][8]. That converts a speculative hardware program into a partially state-underwritten one and signals sovereign preference for domestic superconducting fabrication. The effect persists while appropriations persist, and it materially lowers the perceived probability of a zero. |
| A FOUR YEAR Runway DEBT FREE | Capital Allocation | +25% | +10% | Rigetti held $541.3M in cash and available-for-sale investments with no debt at June 30, 2026, against roughly $28M quarterly burn and $27.8M Q2 free cash outflow [1][2][4]. That is four to five years of financing without a forced raise, which removes the classic pre-revenue death spiral from the bear case. The cash was raised from shareholders, not customers, but for option value what matters is time on the clock. |
| Chiplets Shipped NOT JUST Promised | Innovation And Product | +22% | +60% | Cepheus-1-108Q reached general availability in April 2026: twelve interconnected 9-qubit chiplets, 99.1% median two-qubit fidelity at ~60ns, and the first gate-based device above 100 qubits on Amazon Braket [12][13]. Modular chiplet tiling is the credible path past monolithic yield limits, and a 99.9% prototype two-qubit gate at 28ns shows headroom [12]. Each verified fidelity step re-rates the option, even with negligible revenue attached. |
| ON PREM QPU Sales FIND First Buyers | Competitive Positioning | +15% | +120% | H1 2026 revenue of $9.5M versus $3.3M a year earlier came from Novera on-premises QPU sales, and management expects to book an $8.4M C-DAC order in Q4 2026 [2][15]. National labs and sovereign programs are becoming repeat hardware buyers, giving Rigetti a revenue line independent of cloud intermediaries. It remains research budget money rather than production workload spend, so growth is lumpy but directionally persistent. |
Near-certain negative forces
Top Frictions / Headwinds
Expected frictions that can slow, cap, or damage this advisor thesis. These forces are treated as part of the base case (more than 60% probability of occurrence).
Scroll to view all columns
| Friction / Headwind | Category | Est. stock-price impact | Est. earnings impact | Why it matters |
|---|---|---|---|---|
| Ninety Percent OF Price IS Narrative | Macroeconomic And Macrofinancial | -40% | +0.0% | Net cash of roughly $541M is about $1.60 per share against a $15.76 close and $5.25B market cap [1]; TTM revenue of $13.35M implies a price-to-sales ratio beyond 300x. Every dollar above roughly $2 is an option on milestones management itself dates three years out [16]. With the Fed at 3.75%-4.00% and the 10Y near 5.0%, this ultra-long-duration payoff is discounted harshly whenever thematic flow pauses. |
| Roadmaps Slip; THAT IS THE BASE RATE | Operational Efficiency | -28% | -25% | The 108-qubit launch slipped from end-2025 to Q1 2026 over tunable-coupler complexity and shipped at 99.1% rather than the 99.5% target, which was pushed to end-2026 [11][12][14]. The 336-qubit Lyra, once hoped for 2023, still has no date [17]. Each missed fidelity or qubit-count milestone removes a scheduled catalyst from a stock whose entire valuation is a schedule of catalysts. |
| Shareholders Funded IT Customers DID NO | Management And Governance | -22% | -8.0% | Equity of $546M at FY2025 against cumulative operating losses shows the balance sheet was built by issuance, not operations [4]. Commerce priced its stake at $12.92, near the 52-week low area, establishing a market-linked reference rather than a premium [8]. Expect continued at-the-market issuance to extend runway toward the three-year advantage horizon, diluting per-share option value even when the science advances. |
| Better Capitalized Rivals Crowd THE FIEL | Sector And Industry | -20% | -30% | Quantinuum completed a $1.68B IPO in June 2026 and PsiQuantum raised $1B at a $7B valuation with Nvidia participating [21]; IBM's roadmap targets 1,386-qubit Kookaburra and 4,158-qubit linked systems [22]. Rigetti's scarcity premium as the listed pure-play erodes as peers list and outspend. With AWS and Azure owning the customer layer [5], Rigetti competes on physics while others control distribution and capital. |
3.2. Risks & Opportunities
Plausible downside scenarios
Tail Risks
Less likely downside scenarios that could materially hurt the outcome if they occur.
Scroll to view all columns
| Tail scenario | Chance of Occurring | Stock Price Impact | Why plausible / what changes |
|---|---|---|---|
| Fidelity Target Missed Again | 38% | -55% | If the 99.5% two-qubit fidelity goal slips past end-2026 and the 1,000-qubit path stretches beyond 2029, the market's willingness to underwrite a three-year advantage story collapses [14][15][17]. Coupled with a Commerce milestone tranche being delayed or terminated for non-performance or appropriations lapse [9], the stock loses both its scientific and its political validation simultaneously. Probability under 50% because partial progress usually arrives, even late, and 108Q did eventually ship [12]. |
| Thematic FLOW Reverses Duration Bites | 45% | -45% | A sustained risk-off episode, triggered by another Fed hike toward the 4.1% SEP median or an AI-capex funding accident, would drain the speculative bid that sustains a 300x sales multiple. With roughly 5% of shares turning over daily and a retail-dominated register [20], the unwind is reflexive: falling price shrinks the ATM's capacity, which raises dilution per dollar raised. Most likely 2027, and below 50% only because the $541M cash floor limits how far distress can compound [1]. |
Plausible upside scenarios
Tail Opportunities
Less likely upside scenarios that could materially improve the outcome if they occur.
Scroll to view all columns
| Tail scenario | Chance of Occurring | Stock Price Impact | Why plausible / what changes |
|---|---|---|---|
| Verified Quantum Advantage Lands Early | 25% | +180% | If Rigetti or a partner demonstrates a peer-reviewed, commercially meaningful advantage on a chiplet-based superconducting system, plausibly 2028-2029 given management's three-year framing [16], the entire valuation basis shifts from option value to discounted commercial pipeline. Logical error-corrected demonstrations would pull forward enterprise procurement budgets and trigger index and institutional inclusion. Probability stays below half because the 99.5% fidelity target already slipped once and error-correction overheads remain brutal at 108 physical qubits [11][14]. |
| Strategic Acquirer OR Sovereign Consortium BIDS | 20% | +95% | A hyperscaler, defense prime or allied-government consortium could acquire Rigetti outright to secure domestic superconducting fabrication, most plausibly 2028-2030 once Commerce milestones are complete and the federal equity stake creates a natural counterparty conversation [7][9]. NEC's reported hardware exit and Quantinuum's listing suggest consolidation pressure across the modality [21]. A control premium on a scarce fab-plus-IP asset would reprice sharply. It remains below 50% because government equity and CFIUS-style review complicate any takeout. |
5. References & Context
Search behavior, retained evidence, supplied context, and response token details.External web search was used. The retained search terms and consulted sources are shown below.
Context supplied to the model
Public-safe inputs retained with this immutable forecast publication.
- 01
Market data
inmemory_base_placeholders__latest_eod_close_price_with_stats_and_fundamentals__var1
- 02
Global context in this run
Used
- 03
Fundamental data in this run
Used
- 04
Global context
Standard global market and cross-asset context
- 05
Subject context
Equity-specific subject and market context
- 06
Task framework
Standard investment-forecast task guidelines
- 07
Advisor framework
Universal Investor The Polymath
- 08
Forecast output requested
Equity Extended Investment Thesis (4 Quadrants and Alpha Asymmetry) + Pct Change Timeseries for Close Price with Rationale, (5Y Quarterly)
Global context snapshot
2026 Year-to-Date Global Market and World-Events Context Through September 20
Download Archived SnapshotCoverage 2026-01-01 to 2026-09-20 · Knowledge cutoff 2026-09-20
January 1-September 20, 2026: monetary tightening, energy security, trade restrictions, AI financing and divergent growth; five leading market themes.
Fed raised rates to 3.75%-4.00%; ECB hike is in force and BOJ increase starts September 24. Markets through September 18, bitcoin through September 19.
| Top 3 Market Shifts From File | Date | Status |
|---|---|---|
| Renewed monetary tightening amid persistent inflation | 2026-01-30 | ACTIVE POLICY REGIME |
| Iran/Hormuz conflict and wider energy-security disruption | 2026-02-28 | ONGOING |
| Tariff legal reset and strategic supply restrictions | 2026-02-20 | ACTIVE POLICY REGIME |
Representative Sources of the Context File
And more sources from the retained context package.
Fundamental context
Income statement
9 fieldsdepreciationAndAmortization · ebit · ebitda · grossProfit · +5 more fields
Balance sheet
12 fieldscash · commonStockSharesOutstanding · longTermDebt · netDebt · +8 more fields
Cash flow
3 fieldscapitalExpenditures · freeCashFlow · totalCashFromOperatingActivities
annual: 2019-12-31–2025-12-31, 7 periods; quarterly: 2023-09-30–2026-06-30, 12 periods
Currencies cited: USD (quote USD; primary reporting USD; converted/valuation USD).
Search terms retained
- 1.Rigetti Computing Q2 2026 results cash balance
- 2.Rigetti 336-qubit Lyra system launch
- 3.Rigetti RGTI news September 2026
- 4.Rigetti Cepheus 100+ qubit system 2026 launch fidelity
- 5.Commerce Department $300 million quantum award equity stake Rigetti D-Wave September 2026
Sources retained for this advisor
- [1]Rigetti Computing Reports Second Quarter 2026 Financial Resultsthequantuminsider.com
- [2]Rigetti Computing Reports Second Quarter 2026 Financial ...stocktitan.net
- [3]Rigetti Computing Reports Q2 2026 Financial Results: Revenue Up 185% YoY, $100M CHIPS Act LOI, and HPE Supercomputing Partnership - Quantum Computing Reportquantumcomputingreport.com
- [4]Rigetti Computing Inc (RGTI) Financials FY2025: Revenue $7.1M, Net Loss $216.2M | Income Statement & Balance Sheetstocktitan.net
- [5]Rigetti Computing Inc (RGTI) (Q2 2026) Earnings Call Highlights: Revenue Surges to $5. ... By GuruFocusca.investing.com
- [6]Rigetti Computing Reports Second Quarter 2026 Financial Resultsfinance.yahoo.com
- [7]D-Wave, Rigetti, Quantinuum land $100M each in CHIPS Act fundingqz.com
- [8]CHIPS Quantum Funding Backs D-Wave, Rigetti, Quantinuum | InsiderFinanceinsiderfinance.io
- [9]Commerce Takes Stakes in Three Quantum Firms in $300 Million CHIPS Deal | Superpower Dailysuperpowerdaily.com
- [10]Rigetti Posts Losses, But Moves Forward on Roadmap With 100-Qubit System by End of 2025thequantuminsider.com
- [11]Rigetti Computing Provides Update on 108-Qubit System | Rigetti & Co, LLCinvestors.rigetti.com
- [12]Rigetti Announces General Availability of 108-Qubit System | Rigetti & Co, LLCinvestors.rigetti.com
- [13]Rigetti Announces General Availability of 108-Qubit Systemthequantuminsider.com
- [14]Rigetti Launches 108-Qubit Quantum System, Expanding Modular Architecture — Rigetti Computing, Inc. | BriefGlancebriefglance.com
- [15]Rigetti Computing Inc Stock Price Today | NASDAQ: RGTI Live - Investing.cominvesting.com
- [16]Rigetti Computing's (RGTI) 108-Qubit Cepheus-1 System Targets Quantum Advantage Within Three Yearsforeignpolicyjournal.com
- [17]Rigettipostquantum.com
- [18]Rigetti Computing Reports Second Quarter 2026 Financial Resultsglobenewswire.com
- [19]News Releases | Rigetti & Co, LLCinvestors.rigetti.com
- [20]Rigetti Computing: RGTI Stock Price Quote & News | Robinhoodrobinhood.com
- [21]Commerce Department Takes Equity Stakes in Rigetti, D-Wave and Quantinuum - Startup Fortunestartupfortune.com
- [22]Rigetti Sharpens Focus on Modular, High-Fidelity Quantum Pipelinenasdaq.com
Original published forecast
Inspect the original revision and sealed receipt when a public record is available. Integrity verification is separate from forecast accuracy.
A consensus thesis is not available for this publication.